Revision of Zynerba Pharmaceuticals

{{DISPLAYTITLE:Zynerba Pharmaceuticals}}
Inovio Pharmaceuticals formerly known as Electrofect founded in 1999 renamed to Inovio in October 2001 is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development (June 2020).<small> from [https://en.wikipedia.org/wiki/Inovio_Pharmaceuticals Wikipedia]</small>

{{SF|
{{Twt|zynerbapharma}}
{{Wb|https://zynerba.com/|zynerba.com}}
}}
{{IDF|
{{Wd|Q30283745}}
{{Isni|0000000483070679}}
}}

{{VHID|86631199121}}{{#subtitle: <big>company in Radnor, United States</big>}}